A  NueCura Partners

http://www.nuecura.com/





     Office Locations:

Brentwood, TN

 

Stages:

  • Early
  • Seed


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    NueCura Partners is an angel investment company that focuses on investments in early-stage companies in the healthcare sector. NueCura is managed and driven by seasoned healthcare business operators and experienced investors.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Bill Gates MD Operating Partner
    Chris Taylor Operating Partner
    Don Lazas MD Founder and Managing Partner
    Geof Vickers Advisor and Outside Council
    Jeff Patton MD Senior Advisor

     

    Portfolio companies include:


      Bivarus
        web link


      Clinovo
        web link


      Everly
        web link


      EvidenceCare


      InvisionHeart


      NextGxDx


      RxREVU


      Sano Informed Prescribing


     

    Recent News: